1. Clinical Overview
A sterile suspension of adsorbed, purified diphtheria, tetanus, and acellular pertussis toxoids for active immunization. It is a combined vaccine (DTaP) used in the primary immunization series and booster doses in children from 6 weeks up to 7 years of age to prevent diphtheria, tetanus, and pertussis (whooping cough). The antigens are adsorbed onto aluminum salts (aluminum hydroxide or phosphate) to enhance immunogenicity.
| Onset | Duration | Bioavailability |
|---|---|---|
| Protective antibody levels typically develop within 2-4 weeks after completion of the primary series (3 doses). | Protection lasts for several years. Booster doses are required to maintain immunity. Primary series provides protection for approximately 5-10 years for tetanus and diphtheria; pertussis immunity wanes more quickly, typically 4-6 years. | Not applicable (Parenteral administration). Immunogenicity is the relevant measure, not bioavailability. |
2. Mechanism of Action
The vaccine contains purified, inactivated toxins (toxoids) of *Corynebacterium diphtheriae* and *Clostridium tetani*, and purified, inactivated components (toxoids and other proteins like pertactin, filamentous hemagglutinin) of *Bordetella pertussis*. Upon intramuscular injection, these antigens are taken up by antigen-presenting cells, processed, and presented to helper T cells. This stimulates B lymphocytes to produce specific neutralizing antibodies (IgG) against the respective toxins and bacterial components. Memory B and T cells are also generated, providing long-term immunity.
3. Indications & Uses
- Primary immunization of infants and children from 6 weeks up to 7 years of age against diphtheria, tetanus, and pertussis (whooping cough).
- Booster doses in children as part of the national immunization schedule.
4. Dosage & Administration
Adult Dosage: NOT RECOMMENDED. For adults and adolescents (≥7 years), use Tdap vaccine.
Administration: For intramuscular use only. Shake vial or pre-filled syringe vigorously before use. Preferred site for infants and young children is the anterolateral aspect of the thigh. For older children, the deltoid muscle can be used. Do not inject intravenously, subcutaneously, or intradermally. Use a separate, sterile syringe and needle for each patient. Do not mix with other vaccines in the same syringe.
5. Side Effects
Common side effects may include:
- Pain, redness, and swelling at the injection site (in up to 50% of recipients).
- Mild fever (<102°F or 39°C).
- Fussiness, irritability, drowsiness.
- Loss of appetite.
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Immunosuppressants (e.g., high-dose corticosteroids, chemotherapy, biologics like TNF inhibitors) | Diminished or suboptimal immune response to the vaccine. | Major |
| Immunoglobulins or Blood Products (e.g., IVIG, Rabies Immunoglobulin) | May interfere with the immune response to the vaccine. Administer vaccines at least 2 weeks before or 3-12 months after such products, depending on dose. | Major |
| Anticoagulants (e.g., Warfarin) | Increased risk of bleeding or hematoma at injection site. Use a fine needle (23-25 gauge) and apply firm pressure for ≥2 minutes. | Moderate |
| Other Live Vaccines (e.g., Oral Polio, MMR, Varicella) | No significant interaction. Can be administered simultaneously at different sites. If not given together, a 4-week interval is recommended for live vaccines. | Minor |
7. Patient Counselling
- DO complete the full schedule of 3 primary doses and booster doses for complete protection.
- DO keep a record of your child's vaccination (Mother & Child Protection card).
- DO expect and manage mild side effects like fever with paracetamol (as advised by doctor) and local swelling with cool compresses.
- DO NOT give aspirin to the child for fever management due to risk of Reye's syndrome.
- DO NOT postpone vaccination for mild cold or cough without fever.
8. Toxicology & Storage
Overdose: Overdose is unlikely due to fixed-dose presentation in single-use vials/syringes. Theoretical risks include severe local reaction (pain, swelling), high fever, and exaggerated immune response.
Storage: Store between +2°C to +8°C in a refrigerator. DO NOT FREEZE. Freezing destroys the vaccine potency. Protect from light. Keep in original packaging until use. Do not use if the vaccine has been frozen, is discolored, or contains particulate matter. Use immediately after opening the vial. Discard unused portion.